M. Campreciós

发表

Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.

M. Crespo-Leiro, J. Muñiz, G. Rábago, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

RAndomized Comparison of raDIal vs. femorAL Access for Routine Catheterization of Heart Transplant Patients (RADIAL-heart transplant study).

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2014, Transplantation proceedings.

Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation.

I. Carrió, J. Narula, A. Flotats, 1998, Journal of the American College of Cardiology.

Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis

R. Virmani, F. Kolodgie, J. Marrugat, 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Somatostatin receptor scintigraphy predicts impending cardiac allograft rejection before endomyocardial biopsy

I. Carrió, A. Catafau, J. Narula, 2000, European Journal of Nuclear Medicine.

Distinct left bundle branch block pattern in ischemic and non‐ischemic dilated cardiomyopathy

A. Bayés‐Genís, R. Elosua, A. Luna, 2003, European journal of heart failure.

Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR).

G. Rábago, J. Delgado, E. Roig, 2009, Transplantation proceedings.

The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.

M. Crespo-Leiro, J. Delgado, E. Roig, 2009, Transplantation reviews.

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study

G. Rábago, D. Pascual, E. Roig, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Cerebrovascular Disease as a Complication of Cardiac Transplantation

J. Martí-Fàbregas, J. Martí-Vilalta, R. Belvís, 2005, Cerebrovascular Diseases.

The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

J. Oliveira, A. Ortiz, J. Egido, 2015, Molecular genetics and metabolism.

Spanish Heart Transplant Units Consensus Conference

L. A. Bonet, S. Hunt, D. Pascual, 2007 .

Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts.

S. Serrano, M. Salido, A. Bayés‐Genís, 2002, Cardiovascular research.

Validation of the Agency for Health Care Policy and Research (AHCPR) classification for managing unstable angina.

C. Brotons, I. Moral, J. Soler‐Soler, 1999, Journal of clinical epidemiology.

Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study.

A. Evangelista, J. Soler‐Soler, M. Olona, 1995, American heart journal.

Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging.

I. Carrió, A. Catafau, J. Narula, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tricuspid valve replacement with mechanical prostheses: Short and long‐term outcomes

X. Rosselló, X. Borrás, M. Campreciós, 2017, Journal of cardiac surgery.

Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR).

J. Delgado, J. Arizón, N. Manito, 2009, Transplantation proceedings.